Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana I Rojo

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Redox Biology|July 21, 2018
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathyAna I Rojo, Marta Pajares, Angel J García-Yagüe, et al.
Antioxidants (Basel, Switzerland)|October 27, 2022
Dipeptide Repeat Pathology in <i>C9orf72</i>-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway ImbalanceJosé Jiménez-Villegas, Janine Kirby, Ana Mata, et al.
Free Radical Biology & Medicine|May 8, 2010
The purinergic P2Y(13) receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal deathSandra Espada, Felipe Ortega, Eduardo Molina-Jijón, et al.
Free Radical Biology & Medicine|December 7, 2011
Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3Ana I Rojo, Omar Noel Medina-Campos, Patricia Rada, et al.
Journal of Biomedical Science|July 11, 2025
A novel β-TrCP1/NRF2 interaction inhibitor for effective anti-inflammatory therapyÁngel J García-Yagüe, Lucía Cañizares-Moscato, José Antonio Encinar, et al.
FEBS Letters|December 8, 2004
Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivoMarta Salinas, Jinling Wang, María Rosa de Sagarra, et al.
Redox Biology|March 5, 2026
Hexaraphane as a potential therapeutic strategy for tauopathiesÁngel Juan García-Yagüe, Daniel Carnicero-Senabre, Ángel Núñez, et al.
Free Radical Biology & Medicine|September 13, 2022
Overlooked and valuable facts to know in the NRF2/KEAP1 fieldAleksandra Kopacz, Ana I Rojo, Chinmai Patibandla, et al.
Plos One|August 3, 2010
Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1Nadia G Innamorato, Agnieszka Jazwa, Ana I Rojo, et al.
Free Radical Biology & Medicine|August 2, 2025
Dual targeting of Keap1 and Gsk-3 by hexaraphane in the regulation of transcription factor Nrf2Ángel J García-Yagüe, Eduardo J Cueto-Díaz, Maribel Escoll, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Redox Biology|July 21, 2018
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathyAna I Rojo, Marta Pajares, Angel J García-Yagüe, et al.
Antioxidants (Basel, Switzerland)|October 27, 2022
Dipeptide Repeat Pathology in <i>C9orf72</i>-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway ImbalanceJosé Jiménez-Villegas, Janine Kirby, Ana Mata, et al.
Free Radical Biology & Medicine|May 8, 2010
The purinergic P2Y(13) receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal deathSandra Espada, Felipe Ortega, Eduardo Molina-Jijón, et al.
Free Radical Biology & Medicine|December 7, 2011
Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3Ana I Rojo, Omar Noel Medina-Campos, Patricia Rada, et al.
Journal of Biomedical Science|July 11, 2025
A novel β-TrCP1/NRF2 interaction inhibitor for effective anti-inflammatory therapyÁngel J García-Yagüe, Lucía Cañizares-Moscato, José Antonio Encinar, et al.
FEBS Letters|December 8, 2004
Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivoMarta Salinas, Jinling Wang, María Rosa de Sagarra, et al.
Redox Biology|March 5, 2026
Hexaraphane as a potential therapeutic strategy for tauopathiesÁngel Juan García-Yagüe, Daniel Carnicero-Senabre, Ángel Núñez, et al.
Free Radical Biology & Medicine|September 13, 2022
Overlooked and valuable facts to know in the NRF2/KEAP1 fieldAleksandra Kopacz, Ana I Rojo, Chinmai Patibandla, et al.
Plos One|August 3, 2010
Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1Nadia G Innamorato, Agnieszka Jazwa, Ana I Rojo, et al.
Free Radical Biology & Medicine|August 2, 2025
Dual targeting of Keap1 and Gsk-3 by hexaraphane in the regulation of transcription factor Nrf2Ángel J García-Yagüe, Eduardo J Cueto-Díaz, Maribel Escoll, et al.
Pageof 7